Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|14|2160-2169

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.14, 2016-04, pp. : 2160-2169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuronal Nicotinic Acetylcholine Receptors as Pharmacotherapeutic Targets for the Treatment of Alcohol Use Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 1, 2010-03 ,pp. : 60-76

Bentham Science Publishers

Access to resources Recommend Favorite

Neuronal nicotinic acetylcholine receptors as drug targets

By Suto Mark J   Zacharias Niki  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 2, 2004-04 ,pp. : 61-64

Informa Healthcare

Access to resources Recommend Favorite

Nicotinic Acetylcholine Receptors as Drug Targets

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 2, 2004-04 ,pp. : 123-130

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Neuronal Nicotinic Receptors as New Targets for Drug Discovery

By  

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 407-428

Bentham Science Publishers

Access to resources Recommend Favorite

Erysodine, a competitive antagonist at neuronal nicotinic acetylcholine receptors

By Decker M.W.   Anderson D.J.   Brioni J.D.   Donnelly-Roberts D.L.   Chae Hee K.   O'Neill A.B.   Piattoni-Kaplan M.   Swanson S.   Sullivan J.P.  

European Journal of Pharmacology, Vol. 280, Iss. 1, 1995-06 ,pp. : 79-89

Elsevier

Access to resources Recommend Favorite